Htg Molecular Diagnostics Inc (HTGM) Return on Assets ROA from the first quarter of 2023 to first quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Htg Molecular Diagnostics Inc  (NASDAQ: HTGM)


Htg Molecular Diagnostics Inc's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Htg Molecular Diagnostics Inc's ROA in the first quarter of 2023?
Htg Molecular Diagnostics Inc recorded a cumulative net loss of $-20 million during 12 months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -125.34%.

However, within the Healthcare sector 1020 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2023 quarter, so far to 5265, from total ROA ranking in the fourth quarter of 2022 at 5981.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Total Assets Change -62.35 % -41.34 % -60.56 % -40.5 % -22.29 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -20 -22 -22 -22 -19
Return On Assets (TTM) -125.34 % -105.26 % -93.43 % -76.44 % -57.56 %
HTGM's Total Ranking # 5265 # 5981 # 5238 # 5271 # 5058
Total Assets (TTM) in million 11 18 14 22 28
Seq. Total Assets Change -39.72 % 30.62 % -38.71 % -21.99 % -6.08 %
Seq. Net Income Change - - - - -

HTGM's 5 Years Annual ROA >> Back to HTGM Management Effectiveness >> Compare HTGM ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 32
Sector # 1021
Overall # 5152

Return On Assets Statistics
High Average Low
-34.45 %
-68.33 %
-136.19 %
(Dec 31 2018)   (Sep 30 2017)





Financial Statements
Htg Molecular Diagnostics Inc's Assets $ 11 million HTGM's Balance sheet
Htg Molecular Diagnostics Inc's Income $ -5 million Quarterly HTGM's Income Statement
HTGM's Income by Division See HTGM's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change -41.34 % -13.9 % -21.99 % 3.86 % 104.37 %
Total Assets in million 18 30 35 45 43
Y / Y Net Income Change - - - - -
Net Income in million -22 -17 -21 -19 -16
Annual Return On Assets -121.47 % -56.57 % -59.29 % -42.77 % -37.88 %

HTGM's 5 Years Annual ROA >> Back to HTGM Management Effectiveness >> Compare HTGM ROA to its Competitors



More Return On Assets Ratios
HTGM's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HTGM's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HTGM's Competitors
Subscribers only: Roa for Htg Molecular Diagnostics Inc's Suppliers
Subscribers only: Return On Assets for HTGM's Customers

You may also want to know
HTGM's Roi HTGM's Inventory Turnover Ratio HTGM's Growth Rates HTGM's Dividend Comparisons
HTGM's Profitability Ratios HTGM's Asset Turnover Ratio HTGM's Dividend Growth
HTGM's Roe HTGM's Valuation Ratios HTGM's Financial Strength Ratios HTGM's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2023, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:57+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.